Steven Rosenberg, MD
Urology · Urbandale, IANPI 1861488785
Payments from drug & device makers
Across 265 payments — averaging $5031.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma Global Development$562K
- AbbVie$254K
- Dendreon Pharmaceuticals LLC$163K
- Pfizer$100K
- Ferring Pharmaceuticals AS$76K
- Janssen Research & Development, LLC$66K
- plus $113K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma Global Development | 52 | $561,812 |
| AbbVie(2 entities) | 48 | $254,175 |
| Dendreon Pharmaceuticals LLC | 35 | $162,923 |
| Pfizer | 5 | $99,600 |
| Ferring Pharmaceuticals AS | 20 | $75,755 |
| Janssen Research & Development, LLC | 14 | $66,426 |
| Urovant Sciences Inc | 22 | $37,955 |
| Ipsen Innovation | 5 | $28,663 |
| GSK | 11 | $19,100 |
| Myovant Sciences Inc. | 7 | $12,910 |
| Ferring International Pharmascience Center US | 1 | $7,230 |
| Bayer | 11 | $4,391 |
| Sumitomo Pharma America, Inc. | 2 | $1,603 |
| Boston Scientific | 8 | $237 |
| Endo Pharmaceuticals Inc. | 8 | $139 |
| Johnson & Johnson | 1 | $80 |
| Healthtronics Stone Solutions, LLC | 1 | $61 |
| Rochester Medical Corporation | 2 | $40 |
| Axonics, Inc. | 2 | $35 |
| AstraZeneca | 1 | $35 |
| Urogen Pharma, Inc. | 1 | $31 |
| Medtronic | 1 | $25 |
| Merck | 1 | $21 |
| Amgen | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Coloplast | 1 | $14 |
| Endo USA, Inc. | 1 | $14 |
| Ambu Inc. | 1 | $3 |
How this compares
$1,333,329 in reported general payments places this provider in the 95th percentile of 114 urology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Urbandale
- Kevin CwachUrbandale$7K
- Annah VollstedtIowa City$148K
- Karl KrederIowa City$148K
- Vignesh PackiamIowa City$142K
- Michael OdonnellIowa City$128K
- Bradley EricksonIowa City$113K
- Elizabeth TakacsMason City$68K
- Ryan DornbierClive$65K
- Kevin BirusinghDes Moines$59K
- Alexandria HertzIowa City$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.